Related Experiment Video
Updated: Jun 22, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
[Lipid peroxidation and antioxidative protection in patients with coronary heart disease]
Insights
Patients with severe coronary heart disease (CHD) exhibit higher lipid peroxidation products (LPP) and lower antioxidant activity. These markers correlate with lipid composition and homocysteine in stable CHD.
Area of Science:
- Biochemistry
- Cardiology
- Clinical Chemistry
Background:
- Coronary heart disease (CHD) involves complex biochemical alterations.
- Lipid peroxidation products (LPP) and oxidative stress are implicated in CHD pathogenesis.
- Assessing antioxidant system activity is crucial for understanding disease severity.
Purpose of the Study:
- To investigate the relationship between lipid profiles, LPP, homocysteine, and antioxidant enzyme activity in CHD patients.
- To differentiate biochemical markers between functional classes of angina (FC II and FC III).
Main Methods:
- Measurement of total cholesterol, HDL, LDL, and LPP (dienic conjugates, TBA-reactive compounds) in blood samples.
- Quantification of plasma homocysteine and erythrocyte antioxidant enzyme activities (superoxide dismutase, glutathione peroxidase).
- Assessment of plasma ceruloplasmin/transferrin antioxidant system.
Main Results:
- Patients with FC III angina showed significantly elevated LPP levels compared to FC II angina or healthy subjects.
- Lower activity of tissue and plasma antioxidant systems was observed in FC III angina patients.
- Stable CHD patients demonstrated correlations between lipid composition, LPP, homocysteine, and antioxidant enzyme activity.
Conclusions:
- Increased LPP and reduced antioxidant capacity are associated with more severe angina in CHD.
- Biochemical markers including lipids, LPP, homocysteine, and antioxidant enzymes are interconnected in stable CHD.
- These findings highlight the role of oxidative stress and lipid metabolism in CHD progression.
Abstract:
Total cholesterol as well as cholesterol of low and high density lipoproteins, lipid peroxidation products (LPP), such as dienic conjugates and compounds reacting with thiobarbituric acid, were measured in a single blood sample from each of the 295 patients with CHD and 20 apparently healthy subjects. FC II and III angina was diagnosed in 142 and 151 CHD patients respectively. Certain samples were used to additionally detect homocysteine, activity of anti-oxidative enzymes (superoxide dismutase and glutathione peroxidase) in erythrocytes and ceruloplasmin/transferrin anti-oxidative system in plasma. Patients with FC III angina had significantly higher LPP levels but lower activity of tissue and plasma anti-oxidative systems than patients with FC II angina or healthy subjects. Patients with stable forms of CHD showed correlation between lipid composition, LPP contents, homocysteine level, and activity of anti-oxidative enzymes.
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Peroxisomes
Radical Autoxidation

